The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 47 | — | 20.1x | Near average | |
Growth | 63 | 39.6% | 5.6% | Near average | |
Quality | 60 | -59.4% | 7.6% | Near average | |
Safety | 54 | -2.5x | 0.4x | Near average | |
Capital Return | 14 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Guardant Health, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Guardant Health, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Guardant Health stock saw an improvement in its average price target by 3.1% over the past week to reach $138.15, despite the number of following analysts shrinking from 13 to 7, indicating a concentration and alignment of estimates toward higher levels. Analyst dispersion shows a low of 115 and a high of 175, reflecting cautious optimism with a positive price gap compared to the current price of $127.03.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.